Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
COVID-19 Patient Resource Center
Clinical Trials
Search Clinical Trials
Patient Notification System
What is Clinical Research?
Volunteering for a Clinical Trial
Understanding Informed Consent
Useful Resources
FDA Approved Drugs
Professional Resources
Research Center Profiles
Clinical Trial Listings
Market Research
FDA Approved Drugs
Training Guides
Books
Events
Newsletters
JobWatch
White Papers
Patient Education
SOPs
eCFR and Guidances
White Papers
Trial Listings
Advertise
COVID-19
iConnect
Sign In
Create Account
Sign Out
My Account
Home
» Pipeline
Pipeline
June 25, 2018
Company
Drug/Device
Medical Condition
Status
bluebird bio, Inc.
LentiGlobin
anemia
Phase I trial
Kiyatec, Inc.
Ex Vivo 3D (EV3D)
cancer patients with both newly diagnosed and recurrent epithelial ovarian cancer and recurrent high-grade gliomas, which include glioblastomas (GBM)
Phase I trial initiated enrolling 640 subjects
Arrowhead Pharmaceuticals, Inc.
ARO-AAT subcutaneously administered RNA Interference (RNAi) therapeutic
are genetic liver disease associated with alpha-1 antitrypsin deficiency
Phase I trial initiated enrolling 44 subjects
Cambium Medical Technologies
Elate Ocular topical fibrinogen-depleted human platelet lysate biologic
dry eye secondary to graft-versus-host disease
Phase I/II trial initiated
Cefaly Technology
Cefaly ACUTE medical device
acute treatment of migraine
Phase III trial initiated enrolling 309 subjects in the U.S.
Avedro, Inc.
epithelium-on (epi-on) corneal collage cross-linking procedure
progressive keratoconus
Phase III trial initiated enrolling 275 subjects with progressive keratoconus across approximately 20 sites in the U.S.
TransMed7, LLC
SpeedBird platform of soft tissue biopsy devices
soft tissue samples
510(k) Clearance granted by the FDA
Bay Labs
EchoMD AutoEF software
fully automated clip selection and calculation of left ventricular ejection fraction (EF)
510(k) Clearance granted by the FDA
LivaNova PLC
MEMO 4D semi-rigid mitral annuloplasty ring
mitral regurgitation (MR)
510(k) Clearance granted by the FDA
PerkinElmer, Inc.
EUROIMMUN Crithidia luciliae
systemic lupus erythematosus (SLE)
510(k) clearance granted by the FDA
BlueWind Medical
RENOVA iStim implantable Tibial Nerve Neuromodulation System
overactive bladder (OAB)
Approval granted by the FDA
Grifols
Procleix Ultrio Elite
blood screening assay
Approval granted by the FDA
Grifols
Procleix WNV
blood screening assay
Approval granted by the FDA
Caladrius Biosciences, Inc.
CD34+ cell therapy program
refractory angina
RMAT designation granted by the FDA
ImmunoGen, Inc.
mirvetuximab soravtansine
medium-to-high folate receptor alpha (FRα)-positive platinum-resistant ovarian cancer
Fast Track Designation granted by the FDA
Upcoming Events
01
Dec
Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges
02
Dec
Clinical Trial Risk Management in the Post-COVID-19, All-Digital World: Predictive Transformation in Quality, Compliance and Risk Management
02
Dec
2020 in Review: Celebrating the Successes of the Clinical Research Community After A Difficult Year
10
Dec
Medical Device Clinical Trials in China: Latest Regulatory Developments
Featured Products
Regenerative Medicine: Steps to Accelerate Development
Clinical Trial Agreements: A Guide to Key Words and Phrases
Featured Stories
Simple Changes Can Make Trials More Patient Friendly
Two-Thirds of Trial Subjects for Drug Approvals Are Outside the U.S.
Rules of Vaccine Approval May Be Changing, But Statistical Analysis Tools Remain Constant
Ask the Experts: Trial Operations Adjustments in a Remote World
New!
2019 Site Survey Reports
Learn More Here
